The FDA Thursday approved the ARC-EX System designed to restore mobility after spinal cord injury by delivering programmed ...

With the FDA's new requirements for premarket submission and ongoing monitoring by medical device manufacturers in place, ...

To address challenges associated with testing novel medical devices for children and perinatal care, the five-year research partnership will involve sharing de-identified clinical data and using ...

and supporting novel medical devices that address unmet clinical needs and deliver lasting impact. For more information, visit our website www.inquismedical.com or follow us on LinkedIn.

This partnership aims to address long-standing challenges in testing novel medical devices for children and for perinatal care. By sharing de-identified clinical data and leveraging advanced ...

These novel medical devices have the potential to significantly improve the diagnosis and care of patients. Those selected for the pilot include medical devices for cancer and chronic respiratory ...

With approval, the company can begin commercializing the device in the U.S. in 2025.

An expert team led by veteran cardiothoracic surgeon Mani Daneshmand, MD, successfully implanted a novel magnetically ... with the device, joined by other leading medical institutions across ...